Literature DB >> 31656754

Percutaneous kidney ablation: a good option in selected cases.

Samuel Weprin1, Alessandro Veccia1, Riccardo Autorino1.   

Abstract

Year:  2019        PMID： 31656754      PMCID： PMC6789359          DOI： 10.21037/atm.2019.07.85

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

Review 1.  The genomics of renal cell carcinoma and its role in renal mass biopsy.

Authors:  Simpa S Salami; Arvin K George; Aaron M Udager
Journal:  Curr Opin Urol       Date:  2018-07       Impact factor: 2.309

Review 2.  The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.

Authors:  Maciej Salagierski; Adrianna Wojciechowska; Kinga Zając; Tobias Klatte; R Houston Thompson; Jeffrey A Cadeddu; Jihad Kaouk; Riccardo Autorino; Kamran Ahrar; Umberto Capitanio
Journal:  Eur Urol Oncol       Date:  2018-09-24

3.  Prediction of Aggressive Histology: The Ongoing Dilemma of Renal Masses in the "Omics" Era.

Authors:  Uzoma A Anele; Lance J Hampton; Mayer B Grob; Riccardo Autorino
Journal:  Eur Urol       Date:  2018-07-13       Impact factor: 20.096

Review 4.  Role of Active Surveillance for Localized Small Renal Masses.

Authors:  Maria Carmen Mir; Umberto Capitanio; Riccardo Bertolo; Idir Ouzaid; Maciej Salagierski; Maximilian Kriegmair; Alessandro Volpe; Michael A S Jewett; Alexander Kutikov; Phillip M Pierorazio
Journal:  Eur Urol Oncol       Date:  2018-05-26

5.  Renal Mass and Localized Renal Cancer: AUA Guideline.

Authors:  Steven Campbell; Robert G Uzzo; Mohamad E Allaf; Eric B Bass; Jeffrey A Cadeddu; Anthony Chang; Peter E Clark; Brian J Davis; Ithaar H Derweesh; Leo Giambarresi; Debra A Gervais; Susie L Hu; Brian R Lane; Bradley C Leibovich; Philip M Pierorazio
Journal:  J Urol       Date:  2017-05-04       Impact factor: 7.450

6.  Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.

Authors:  Johnathan Doolittle; Joshua Piotrowski; Keegan Zuk; Kenneth Jacobsohn; Peter Langenstroer; William See; Scott Johnson
Journal:  Urology       Date:  2019-07-04       Impact factor: 2.649

7.  Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.

Authors:  Jack R Andrews; Thomas Atwell; Grant Schmit; Christine M Lohse; A Nicholas Kurup; Adam Weisbrod; Matthew R Callstrom; John C Cheville; Stephen A Boorjian; Bradley C Leibovich; R Houston Thompson
Journal:  Eur Urol       Date:  2019-05-03       Impact factor: 20.096

8.  Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.

Authors:  Peter A Caputo; Homayoun Zargar; Daniel Ramirez; Hiury S Andrade; Oktay Akca; Tianming Gao; Jihad H Kaouk
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096

9.  The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.

Authors:  Bimal Bhindi; R Houston Thompson; Christine M Lohse; Ross J Mason; Igor Frank; Brian A Costello; Aaron M Potretzke; Robert P Hartman; Theodora A Potretzke; Stephen A Boorjian; John C Cheville; Bradley C Leibovich
Journal:  Eur Urol       Date:  2018-07-13       Impact factor: 20.096

Review 10.  Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.

Authors:  J Ricardo Rivero; Jose De La Cerda; Hanzhang Wang; Michael A Liss; Ann M Farrell; Ronald Rodriguez; Rajeev Suri; Dharam Kaushik
Journal:  J Vasc Interv Radiol       Date:  2018-01       Impact factor: 3.464
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.